Compare SCYX & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCYX | NSYS |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 40.1M |
| IPO Year | 2014 | 1996 |
| Metric | SCYX | NSYS |
|---|---|---|
| Price | $5.14 | $12.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 239.4K | 14.6K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.36 | ★ 80.85 |
| EPS | N/A | ★ 0.09 |
| Revenue | $257,000.00 | ★ $14,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $608.78 | N/A |
| P/E Ratio | ★ N/A | $141.67 |
| Revenue Growth | N/A | ★ 7.01 |
| 52 Week Low | $0.57 | $6.50 |
| 52 Week High | $5.62 | $18.01 |
| Indicator | SCYX | NSYS |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 38.56 |
| Support Level | $0.65 | $11.94 |
| Resistance Level | $5.58 | $15.35 |
| Average True Range (ATR) | 0.44 | 1.06 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 85.57 | 7.98 |
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.